Insulet
PODD
#1061
Rank
NZ$36.36 B
Marketcap
NZ$516.55
Share price
0.85%
Change (1 day)
13.76%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$2.39 Billion

According to Insulet's latest financial reports the company has NZ$2.39 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Insulet - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$2.14 B85.42%
2023-12-31$NZ$1.15 B54.41%
2022-12-31$NZ$0.75 B-7.87%
2021-12-31$NZ$0.81 B-2.64%
2020-12-31$NZ$0.83 B642.28%
2019-12-31$NZ$0.11 B-64.36%
2018-12-31$NZ$0.31 B41.67%
2017-12-31$NZ$0.22 B144.83%
2016-12-31$NZ$91.16 M83.24%
2015-12-31$NZ$49.75 M-53.5%
2014-12-31$NZ$0.10 B-29.44%
2013-12-31$NZ$0.15 B182.35%
2012-12-31$NZ$53.7 M-49.34%
2011-12-31$NZ$0.10 B23.48%
2010-12-31$NZ$85.84 M17.97%
2009-12-31$NZ$72.77 M50.26%
2008-12-31$NZ$48.43 M-59.8%
2007-12-31$NZ$0.12 B-183.4%
2006-12-31$-NZ$0.15 Billion49.39%
2005-12-31$-NZ$96.7 Million55.02%
2004-12-31$-NZ$62.38 Million32.29%
2003-12-31$-NZ$47.16 Million32.29%
2002-12-31$-NZ$35.65 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ICU Medical
ICUI
NZ$3.67 B 53.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ$0.22 B-90.39%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.71 B 96.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$137.08 B 5,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$88.64 B 3,603.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$83.23 B 3,377.06%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$41.24 B 1,622.95%๐Ÿ‡บ๐Ÿ‡ธ USA